DK3268493T3 - Fuldblodsbaserede mrna-markører til forudsigelse af prostatakræft og fremgangsmåder til detektering deraf - Google Patents
Fuldblodsbaserede mrna-markører til forudsigelse af prostatakræft og fremgangsmåder til detektering deraf Download PDFInfo
- Publication number
- DK3268493T3 DK3268493T3 DK16713202.6T DK16713202T DK3268493T3 DK 3268493 T3 DK3268493 T3 DK 3268493T3 DK 16713202 T DK16713202 T DK 16713202T DK 3268493 T3 DK3268493 T3 DK 3268493T3
- Authority
- DK
- Denmark
- Prior art keywords
- detecting
- methods
- prostate cancer
- whole blood
- mrna markers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562132064P | 2015-03-12 | 2015-03-12 | |
| PCT/US2016/022004 WO2016145308A2 (en) | 2015-03-12 | 2016-03-11 | Whole blood based mrna markers for predicting prostate cancer and methods of detecting the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3268493T3 true DK3268493T3 (da) | 2022-03-07 |
Family
ID=55642872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16713202.6T DK3268493T3 (da) | 2015-03-12 | 2016-03-11 | Fuldblodsbaserede mrna-markører til forudsigelse af prostatakræft og fremgangsmåder til detektering deraf |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20160304962A1 (da) |
| EP (1) | EP3268493B1 (da) |
| JP (1) | JP2018507702A (da) |
| KR (1) | KR20170136525A (da) |
| CN (1) | CN107567502A (da) |
| CA (1) | CA2979226A1 (da) |
| CY (1) | CY1125020T1 (da) |
| DK (1) | DK3268493T3 (da) |
| ES (1) | ES2905163T3 (da) |
| HR (1) | HRP20220128T1 (da) |
| HU (1) | HUE058025T2 (da) |
| IL (1) | IL254119A0 (da) |
| LT (1) | LT3268493T (da) |
| MA (1) | MA45480A (da) |
| PL (1) | PL3268493T3 (da) |
| PT (1) | PT3268493T (da) |
| RS (1) | RS62972B1 (da) |
| SI (1) | SI3268493T1 (da) |
| WO (1) | WO2016145308A2 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180057889A1 (en) | 2015-03-25 | 2018-03-01 | The General Hospital Corporation | Digital Analysis of Circulating Tumor Cells in Blood Samples |
| US11371101B2 (en) | 2016-10-27 | 2022-06-28 | The General Hospital Corporation | Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers |
| CN107338319A (zh) * | 2017-08-25 | 2017-11-10 | 天津艾至恩医疗科技有限公司 | 一种核苷酸引物及预测前列腺癌去势术预后的基因多态性检测试剂盒 |
| CN110760585B (zh) * | 2019-11-07 | 2022-12-09 | 深圳市华启生物科技有限公司 | 前列腺癌生物标志物及其应用 |
| CN111500728A (zh) * | 2020-05-13 | 2020-08-07 | 无锡市申瑞生物制品有限公司 | 检测人ar-v7及ar基因表达的引物探针组合物、试剂盒及检测方法 |
| WO2023220314A1 (en) * | 2022-05-12 | 2023-11-16 | Veracyte SD, Inc. | Prognosis and treatment of molecular subtypes of prostate cancer |
| KR20240022906A (ko) * | 2022-08-12 | 2024-02-20 | (주)맥시온 | 암 진단용 다중 바이오마커 및 이의 용도 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2836128T3 (es) * | 2008-04-16 | 2021-06-24 | Univ Johns Hopkins | Método para determinar variantes del receptor de andrógenos en cáncer de próstata |
| EP2885428B1 (en) * | 2012-08-17 | 2017-05-03 | Memorial Sloan-Kettering Cancer Center | Gene expression profile associated with prostate cancer |
| JP6663347B2 (ja) * | 2013-03-15 | 2020-03-11 | ヤンセン ファーマシューティカ エヌ．ベー． | 予測バイオマーカーのためのアッセイ |
-
2016
- 2016-03-11 HR HRP20220128TT patent/HRP20220128T1/hr unknown
- 2016-03-11 EP EP16713202.6A patent/EP3268493B1/en active Active
- 2016-03-11 CN CN201680015329.2A patent/CN107567502A/zh active Pending
- 2016-03-11 PT PT167132026T patent/PT3268493T/pt unknown
- 2016-03-11 PL PL16713202T patent/PL3268493T3/pl unknown
- 2016-03-11 KR KR1020177028155A patent/KR20170136525A/ko unknown
- 2016-03-11 CA CA2979226A patent/CA2979226A1/en not_active Abandoned
- 2016-03-11 WO PCT/US2016/022004 patent/WO2016145308A2/en active Application Filing
- 2016-03-11 ES ES16713202T patent/ES2905163T3/es active Active
- 2016-03-11 RS RS20220141A patent/RS62972B1/sr unknown
- 2016-03-11 DK DK16713202.6T patent/DK3268493T3/da active
- 2016-03-11 MA MA045480A patent/MA45480A/fr unknown
- 2016-03-11 JP JP2017548024A patent/JP2018507702A/ja active Pending
- 2016-03-11 HU HUE16713202A patent/HUE058025T2/hu unknown
- 2016-03-11 SI SI201631473T patent/SI3268493T1/sl unknown
- 2016-03-11 US US15/067,716 patent/US20160304962A1/en not_active Abandoned
- 2016-03-11 LT LTEPPCT/US2016/022004T patent/LT3268493T/lt unknown
-
2017
- 2017-08-23 IL IL254119A patent/IL254119A0/en unknown
-
2022
- 2022-02-21 CY CY20221100142T patent/CY1125020T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107567502A (zh) | 2018-01-09 |
| LT3268493T (lt) | 2022-03-10 |
| KR20170136525A (ko) | 2017-12-11 |
| PT3268493T (pt) | 2022-04-13 |
| SI3268493T1 (sl) | 2022-04-29 |
| JP2018507702A (ja) | 2018-03-22 |
| MA45480A (fr) | 2018-01-17 |
| US20160304962A1 (en) | 2016-10-20 |
| EP3268493B1 (en) | 2022-01-05 |
| WO2016145308A3 (en) | 2016-10-13 |
| HUE058025T2 (hu) | 2022-06-28 |
| IL254119A0 (en) | 2017-10-31 |
| PL3268493T3 (pl) | 2022-05-09 |
| CA2979226A1 (en) | 2016-09-15 |
| WO2016145308A2 (en) | 2016-09-15 |
| RS62972B1 (sr) | 2022-03-31 |
| EP3268493A2 (en) | 2018-01-17 |
| CY1125020T1 (el) | 2023-03-24 |
| HRP20220128T1 (hr) | 2022-04-29 |
| ES2905163T3 (es) | 2022-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3268493T3 (da) | Fuldblodsbaserede mrna-markører til forudsigelse af prostatakræft og fremgangsmåder til detektering deraf | |
| DK3443119T3 (da) | Fremgangsmåde til bestemmelse af lunge cancer | |
| DK3471749T3 (da) | Fremgangsmåder og sammensætninger til detektering af en mål-RNA | |
| DK3159406T3 (da) | Kit eller indretning til påvisning af øsufagus-cancer og fremgangsmåde til påvisning | |
| DK3262190T3 (da) | Biomarkørpanel til påvisning af cancer | |
| DK3312749T3 (da) | Fremgangsmåder og anordninger til forudsigelse af risiko for prostatacancer og prostatakirtelvolumen | |
| DK3245225T3 (da) | Sammensætninger og fremgangsmåder til behandling og detektering af cancere | |
| DK3398022T3 (da) | Systemer og fremgangsmåder til tilpasning af uav-bane | |
| DK3259386T3 (da) | Systemer og fremgangsmåder til udførelse af immunoassays | |
| BR112017015413A2 (pt) | método e sistema para a determinação do estado de câncer | |
| DK3357000T3 (da) | Systemer og fremgangsmåder til cancerdetektering | |
| DK3156503T3 (da) | Mavecancer-biomarkør og detektionsfremgangsmåde | |
| IL253710A0 (en) | Biomarkers for pancreatic cancer, and kits and methods to detect them | |
| DK3356558T3 (da) | Sirs patogenbiomarkører og anvendelser deraf | |
| DK3344805T3 (da) | Fremgangsmåde til udvælgelse af aptamerer til ubundne mål | |
| DK3336197T3 (da) | Epigenetiske markører og relaterede fremgangsmåder og midler til detektion og behandling af ovariekræft | |
| DK3254093T3 (da) | Fremgangsmåde og anordning til bestemmelse af vandindhold | |
| DK3152569T3 (da) | Midler og fremgangsmåder til bestemmelse af t-cellegenkendelse | |
| DK3128910T3 (da) | Fremgangsmåde til bestemmelse af tværsnitsarealet og voluminet af et objekt | |
| DK3253800T3 (da) | Prostata antigen standarder og bruge deraf | |
| DK3170784T3 (da) | Fremgangsmåde til drift af et ankerspil og ankerspil | |
| DK3293201T3 (da) | Kombinering af adenovirus og checkpoint-inhibitorer til behandling af cancer | |
| DK3230731T3 (da) | Analysesystem til analysering af vand og spildevand | |
| DK3377654T3 (da) | Systemer og fremgangsmåder til identificering af og skelnen mellem genetiske prøver | |
| DK3346091T3 (da) | Anordning og fremgangsmåder til cementerede flerzonekompletteringer |